3Mills RM, LeJemtel TH, Horton DP, et al. Sustained hemodynamie effeets of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure[J]. J Am Coll Cardiol, 1999,34,155--162.
4Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure[J]. N Engl J Med, 2000, 343:246--253.
5Fischer Y, Filzmaier K, Stiegler H, et al. Evaluation of a new,rapid bedside test for quantitative determination of B-type natriuretic peptide[J]. Clinical Chemistry, 2001, 47(3): 591--594.
6Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting[J]. J Am Coll Cardiol, 2001, 37:379--385.
8Suzuki T, Yamaoki K, Nakajima O, et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels[J]. Jpn Heart J, 2000, 41: 205--214.
9Smith H, Pickering RM, Struthers A, et al. Biochemical diagnosis of ventrieular dysfunction in elderly patients in general practice: observational study[J]. BMJ, 2000, 320:906--908.
10Stanek B, Frey B, Httlsmann M, et al. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction[J]. J Am Coll Cardiol, 2001, 38:436--442.
8Tschope C, Kasner M, Westermann D, et al. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements [ J ]. Eur Heart J, 2005, 26(21 ) :2277 -2284.
9Iwanaga Y, Nishi I, Furuichi S, et al. B-Type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure[J].J Am Coll Cardiol, 2006, 47 (4) :742 -748.
10Vanderheyden M, Goethals M, Verstreken S, et al. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy [ J ]. J Am Coll Cardiol, 2004, 44 ( 12 ) : 2349 - 2354.
